Complete remission after myeloablation with bone-seeking 186Re-HEDP and high-dose melphalan followed by autologous stem cell transplantation in a patient with chemorefractory multiple myeloma. [electronic resource]
Producer: 20051006Description: 89-90 p. digitalISSN:- 0268-3369
- Bone and Bones -- metabolism
- Disease-Free Survival
- Etidronic Acid -- pharmacokinetics
- Humans
- Melphalan -- therapeutic use
- Middle Aged
- Multiple Myeloma -- therapy
- Myeloablative Agonists -- therapeutic use
- Organometallic Compounds -- pharmacokinetics
- Peripheral Blood Stem Cell Transplantation -- methods
- Radioisotopes -- therapeutic use
- Remission Induction -- methods
- Rhenium -- therapeutic use
- Salvage Therapy -- methods
- Transplantation, Autologous
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.